tiprankstipranks
Urogen Pharma (URGN)
NASDAQ:URGN

Urogen Pharma (URGN) Technical Analysis

427 Followers

Technical Sentiment

Overall Consensus
Strong Buy
17Bullish
5Neutral
0Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Urogen Pharma’s (URGN) Moving Averages Convergence Divergence (MACD) indicator is 0.51, suggesting Urogen Pharma is a Buy.
Urogen Pharma’s (URGN) 20-Day exponential moving average is 16.08, while Urogen Pharma’s (URGN) share price is $17.92, making it a Buy.
Urogen Pharma’s (URGN) 50-Day exponential moving average is 15.33, while Urogen Pharma’s (URGN) share price is $17.92, making it a Buy.

Urogen Pharma (URGN) Pivot Points

Jul 22, 2024, 11:09 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.61
16.03
16.46
16.88
17.31
17.73
18.16
Fibonacci
16.03
16.35
16.56
16.88
17.20
17.41
17.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (URGN) Moving Averages

Jul 22, 2024, 11:09 AM
Period
Simple
Exponential
MA5
16.59Buy
16.61Buy
MA10
16.23Buy
16.43Buy
MA20
16.71Buy
16.08Buy
MA50
14.68Buy
15.33Buy
MA100
15.13Buy
15.14Buy
MA200
14.58Buy
15.09Buy
Urogen Pharma’s (URGN) 10-Day exponential moving average is 16.43, while Urogen Pharma’s (URGN) share price is $17.92, making it a Buy.
Urogen Pharma’s (URGN) 100-Day exponential moving average is 15.14, while Urogen Pharma’s (URGN) share price is $17.92, making it a Buy.
Urogen Pharma’s (URGN) stock price is $17.92 and Urogen Pharma’s (URGN) 50-day simple moving average is 14.68, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $17.92 and Urogen Pharma’s (URGN) 100-day simple moving average is 15.13, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $17.92 and Urogen Pharma’s (URGN) 200-day simple moving average is 14.58, creating a Buy signal.

Urogen Pharma (URGN) Technical Indicators

Jul 22, 2024, 11:09 AM
Name
Value
Implied Action
RSI (14)
57.08
Neutral
STOCH (9,6)
76.18
Neutral
STOCHRSI (14)
68.14
Neutral
MACD (12,26)
0.51
Buy
ADX (14)
16.28
Buy
Williams %R
-24.72
Buy
CCI (14)
24.68
Neutral
ATR (14)
1.05
-
Ultimate Oscillator
52.24
Neutral
ROC
2.54
Buy
Urogen Pharma’s (URGN) Relative Strength Index (RSI) is 57.08, creating a Neutral signal.
Urogen Pharma’s (URGN) Trend Strength Indicator (ADX) is 16.28, creating a Buy signal.
Urogen Pharma’s (URGN) Commodity Channel Index (CCI) is 24.68, creating a Neutral signal.
Urogen Pharma’s (URGN) Price Rate of Change (ROC) is 2.54, creating a Buy signal.

FAQ

Is URGN a Buy, Hold, or Sell?
Based on URGN’s technical indicators, URGN is a Strong Buy.
    What is URGN’s RSI (14)?
    URGN’s RSI (14) is 57.08, which suggests URGN is a Neutral.
      What is URGN’s MACD?
      URGN’s MACD is 0.51, which suggests URGN is a Buy.
        What is URGN’s 5-day moving average?
        URGN’s 5-day moving average is 16.59, which suggests URGN is a Buy.
          What is URGN’s 20-day moving average?
          URGN 20-day moving average is 16.71, which suggests URGN is a Buy.
            What is URGN’s 50-day moving average?
            URGN’s 50-day moving average is 14.68, which suggests URGN is a Buy.
              What is URGN’s 200-day moving average?
              URGN’s 200-day moving average is 14.58, which suggests URGN is a Buy.
                What is URGN’s Williams % R (14)?
                URGN’s Williams % R (14) is -24.72, which suggests URGN is a Buy.
                  What is URGN’s CCI (14)?
                  URGN’s CCI (14) is 24.68, which suggests URGN is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis